SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-093929
Filing Date
2024-04-12
Accepted
2024-04-12 07:36:31
Documents
15
Period of Report
2024-04-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d748852d8k.htm   iXBRL 8-K 33450
2 EX-10.1 d748852dex101.htm EX-10.1 14095
3 EX-99.1 d748852dex991.htm EX-99.1 17256
  Complete submission text file 0001193125-24-093929.txt   204621

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ivvd-20240411.xsd EX-101.SCH 2839
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ivvd-20240411_lab.xml EX-101.LAB 18738
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ivvd-20240411_pre.xml EX-101.PRE 11700
18 EXTRACTED XBRL INSTANCE DOCUMENT d748852d8k_htm.xml XML 3756
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40703 | Film No.: 24839995
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)